Press Releases
European Commission approves Esmya® for the pre-operative treatment of...
Gedeon Richter Plc. announced today that the European Commission has granted marketing authorization to Esmya® 5mg tablet as pre-operative treatment of moderate to severe...
Press Releases
FDA Grants Orphan Drug Status for CF102 for the...
Can-Fite BioPharma Ltd , a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv...
Press Releases
ELC Group launches new software subsidiary Pharma eReport to...
ELC Group, the pan-European pharmaceutical regulatory affairs organisation, today announces the launch of a new subsidiary, Pharma eReport – a software and services company...
Press Releases
Provepharm announces impressive trading and financial results for 2011
Provepharm, which is specialized in the development of pharmaceutical applications, announces today very healthy trading and financial results for 2011. The company broke even for...
Press Releases
DNA Electronics CEO Professor Chris Toumazou To Address Scripps...
DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that DNA Electronics Chairman and CEO Professor Chris Toumazou...
Press Releases
Ferrer announces best-in-class results in phase I for Lorediplon...
Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to distribution, today announces that it has completed phase I clinical trials...
Press Releases
Pharmaceutical regulatory affairs specialist ELC Group establishes global HQ...
Cambridge, UK, February 8 2012 – ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, today formally announces that it has established its global headquarters...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.